EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, YSB's enterprise value is HK$3,482 Mil.
YSB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-3,500 Mil. Therefore, YSB's EV-to-EBITDA for today is -0.99.
The historical rank and industry rank for YSB's EV-to-EBITDA or its related term are showing as below:
HKSE:09885'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -24.76 Med: -2.1 Max: -0.2
Current: -0.99
During the past 4 years, the highest EV-to-EBITDA of YSB was -0.20. The lowest was -24.76. And the median was -2.10.
HKSE:09885's EV-to-EBITDA is ranked worse than 100% of 467
companies
in the Healthcare Providers & Services industry
Industry Median: 12.46
vs HKSE:09885: -0.99
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-06-23), YSB's stock price is HK$8.15.
YSB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-25.988. Therefore, YSB's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
YSB EV-to-EBITDA Historical Data
The historical data trend for YSB's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, YSB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YSB's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, YSB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where YSB's EV-to-EBITDA falls into.
YSB's current Enterprise Value is HK$3,482 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. YSB's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-3,500 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YSB (HKSE:09885) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
YSB's share price for today is HK$8.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. YSB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-25.988.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of YSB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09885 has been successfully added to your